ES2149771T3 - Produccion de fosfopeptidos a partir de la caseina. - Google Patents

Produccion de fosfopeptidos a partir de la caseina.

Info

Publication number
ES2149771T3
ES2149771T3 ES92908863T ES92908863T ES2149771T3 ES 2149771 T3 ES2149771 T3 ES 2149771T3 ES 92908863 T ES92908863 T ES 92908863T ES 92908863 T ES92908863 T ES 92908863T ES 2149771 T3 ES2149771 T3 ES 2149771T3
Authority
ES
Spain
Prior art keywords
phosphopeptides
solution
caseina
exclusion
coded
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92908863T
Other languages
English (en)
Inventor
Eric Charles Reynolds
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
VICTORIAN DAIRY IND
Victorian Dairy Industry Authority
University of Melbourne
Original Assignee
VICTORIAN DAIRY IND
Victorian Dairy Industry Authority
University of Melbourne
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by VICTORIAN DAIRY IND, Victorian Dairy Industry Authority, University of Melbourne filed Critical VICTORIAN DAIRY IND
Application granted granted Critical
Publication of ES2149771T3 publication Critical patent/ES2149771T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4732—Casein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

UN METODO PARA LA PREPARACION DE FOSFOPEPTIDAS CODIFICADAS QUE TIENEN ACTIVIDAD ANTI ENTE, SOLUBLE, DE CASEINA EN SOLUCION CON UNA ENZIMA PROTEOLITICA, AÑADIR UN ACIDO MINERAL A LA SOLUCION PARA AJUSTAR EL PH A ALREDEDOR DE 4,7, RETIRANDO CUALQUIER PRECIPITADO PRODUCIDO, AÑADIR CACL2 A UN NIVEL DE ALREDEDOR DE 1,0 % W/V PARA OCASIONAR LA AGREGACION DE AL MENOS LAS FOSFOPEPTIDAS CODIFICADAS EN DICHA SOLUCION, SEPARAR LAS FOSFOPEPTIDAS AGREGADAS A PARTIR DE LA SOLUCION A TRAVES DE UN FILTRO QUE TIENE UN LIMITE DE EXCLUSION DE PESO MOLECULAR QUE CAE SUSTANCIALMENTE DENTRO DEL RANGO 10.000 A 20.000 MIENTRAS QUE PASA EL GRUESO DE LAS FOSFOPEPTIDAS Y SOLUCION RESTANTE, DIAFILTRAR LAS FOSFOPEPTIDAS AISLADAS CON AGUA A TRAVES DE UN FILTRO Y CONCENTRAR Y SECAR LO OBTENIDO.
ES92908863T 1991-04-19 1992-04-16 Produccion de fosfopeptidos a partir de la caseina. Expired - Lifetime ES2149771T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPK570691 1991-04-19

Publications (1)

Publication Number Publication Date
ES2149771T3 true ES2149771T3 (es) 2000-11-16

Family

ID=3775351

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92908863T Expired - Lifetime ES2149771T3 (es) 1991-04-19 1992-04-16 Produccion de fosfopeptidos a partir de la caseina.

Country Status (12)

Country Link
US (1) US6448374B1 (es)
EP (1) EP0580694B1 (es)
JP (1) JP3234222B2 (es)
AT (1) ATE194623T1 (es)
AU (1) AU653401B2 (es)
CA (1) CA2108678C (es)
DE (1) DE69231246T2 (es)
DK (1) DK0580694T3 (es)
ES (1) ES2149771T3 (es)
GR (1) GR3034594T3 (es)
NZ (1) NZ242415A (es)
WO (1) WO1992018526A1 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK114392D0 (da) * 1992-09-17 1992-09-17 Kem En Tec As Isolering af biomolekyler
AUPP494798A0 (en) 1998-07-29 1998-08-20 Pacific Biolink Pty Limited Protective protein formulation
WO2006067163A2 (en) * 2004-12-22 2006-06-29 Dsm Ip Assets B.V. Blood pressure lowering oligopeptides in a single enzymatic step
AU2006242842B2 (en) * 2005-05-02 2011-12-08 Mileutis Ltd. Pharmaceutical compositions comprising casein derived peptides and methods of use thereof
US9060947B2 (en) 2009-08-03 2015-06-23 Mcneil-Ppc, Inc. Tooth sensitivity treatment compositions
US8632754B2 (en) 2009-08-03 2014-01-21 Mcneil-Ppc, Inc. Tooth sensitivity treatment compositions
US8603442B2 (en) 2009-08-03 2013-12-10 Mcneil-Ppc, Inc. Tooth sensitivity treatment compositions
CN115594749A (zh) * 2022-10-10 2023-01-13 西南民族大学（Cn） 一种酪蛋白磷酸肽的提取纯化方法
CN117204502B (zh) * 2023-08-25 2024-05-24 广州绿萃生物科技有限公司 一种β-酪蛋白磷酸肽产品的制备方法及其应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2474829B1 (fr) * 1980-02-01 1983-09-09 Agronomique Inst Nat Rech Procede de traitement d'une matiere a base de caseine contenant des phosphocaseinates de cations monovalents ou leurs derives, produits obtenus et applications
JPS58170440A (ja) * 1982-03-30 1983-10-07 Meiji Seika Kaisha Ltd 健康飲食品
GB8811829D0 (en) * 1988-05-19 1988-06-22 Unilever Plc Oral compositions
US4900450A (en) * 1988-07-01 1990-02-13 Culligan International Company Removing residual alkali metal ions from demineralized water
FR2650955B1 (fr) * 1989-08-16 1992-01-10 Agronomique Inst Nat Rech Procede d'obtention, a partir de la caseine beta, de fractions enrichies en peptides a activite biologique et les fractions peptidiques obtenues
EP0523776A3 (en) * 1991-07-17 1993-05-26 Unilever N.V. Oral compositions containing a phosphopeptide
US5227154A (en) * 1991-08-22 1993-07-13 The University Of Melbourne Phosphopeptides for the treatment of dental calculus

Also Published As

Publication number Publication date
GR3034594T3 (en) 2001-01-31
ATE194623T1 (de) 2000-07-15
CA2108678C (en) 2002-09-10
CA2108678A1 (en) 1992-10-20
AU1646892A (en) 1992-11-17
DE69231246D1 (de) 2000-08-17
EP0580694A1 (en) 1994-02-02
EP0580694A4 (en) 1995-12-27
NZ242415A (en) 1993-10-26
DK0580694T3 (da) 2002-05-27
US6448374B1 (en) 2002-09-10
EP0580694B1 (en) 2000-07-12
DE69231246T2 (de) 2001-03-01
JP3234222B2 (ja) 2001-12-04
JPH06506458A (ja) 1994-07-21
WO1992018526A1 (en) 1992-10-29
AU653401B2 (en) 1994-09-29

Similar Documents

Publication Publication Date Title
MX9301767A (es) Particulas de carbonato de calcio precipitado, aglomeradas.
ES2082280T3 (es) Un metodo para tratar aguas residuales de bctmp y ctmp.
ATE196089T1 (de) Mittel zur hemmung des komplementsystems hergestellt aus fucanen aus braunen algen
ES2168300T3 (es) Separacion de proteinas.
BR9910279A (pt) Produto nutricional lìquido, processo para preparar uma composição nutricional lìquida, e, composição nutricionalmente completa
PT762897E (pt) Metodo de prevencao da agregacao de proteinas/peptidos por re-hidratacao ou descongelacao
BR9913945A (pt) Composição farmacêutica para o tratamento de distúrbios agudos por meio de administração sublingual, e, processo para o tratamento de distúrbios agudos
ES2063882T5 (es) Hidrolizados de proteinas.
ES2150948T3 (es) Analogos de pth.
IT1229075B (it) Medicamenti per uso topico, ottenuti tramite l'impiego dell'acido ialuronico
ATE360366T1 (de) Plasmidstabilisierungssystem für die verabreichung von antigenen
ES8601108A1 (es) Procedimiento para la obtencion de eglinas b o c modificadas
ES2093674T3 (es) Polipeptido capaz de interaccionar con trombina.
BR0012693A (pt) Variante, de protease tipo subtilisina; composição de limpeza; e composição de cuidado pessoal
DE69429365D1 (de) Entzündungshemmende zusammensetzung und methode, in welchen des-tyr dynorphin und analoge benutzt werden
ES2185628T3 (es) Procedimiento para preparar proteinas modificadas.
ITRM910430A1 (it) Composizioni farmaceutiche di somatostatina con assorbimento migliorato, loro preparazione e loro impiego
ES2057020T3 (es) Procedimiento para la obtencion de 2,2,4-trimetil-1,2-dihidroquinolina oligomera.
ATE175975T1 (de) Verdrängungschromatographisches verfahren und gereinigtes hämoglobin
DE69231246D1 (de) Herstellung von phosphopeptiden ausgehend von kasein
ES2162305T3 (es) Procedimiento de preparacion de xilitol.
ES2078485T3 (es) Procedimiento de preparacion de dispersiones acuosas de particulas de polimero magnetizable de distribucion estrecha.
ES2034969T3 (es) Un metodo para purificar un fosfato de azucar o su sal de metal alcalino.
Hawkins et al. American concrete institute considerations for fatigue
DK1624057T3 (da) Hyaluronidaseholdigt præparat samt dets farmaceutiske anvendelse

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 580694

Country of ref document: ES